Cognito Therapeutics, which is in late-stage development of its device to treat neurodegenerative diseases like Alzheimer’s, hauled in $105 million in an oversubscribed series C funding round. The ...

Gamma oscillations, brain activity needed for sensory processing, cognition and memory consolidation, are disrupted in Alzheimer’s. Research in mice suggests evoking the oscillations with light and ...

Cognito Therapeutics, a company using visual and auditory stimulation to treat neurodegenerative disorders, announced it closed an oversubscribed $105 million Series C funding round. Morningside ...

Mario Aguilar covers technology in health care, including artificial intelligence, virtual reality, wearable devices, telehealth, and digital therapeutics. His stories explore how tech is changing the ...

Series C proceeds position Spectris for pivotal top-line data, regulatory submission, and launch planning ahead of a targeted 2027 U.S. market entry. Spectris delivers coordinated visual and auditory ...

Cognito Therapeutics, a Cambridge neurotech startup, has locked in a $105 million financing round to drive its at-home Alzheimer’s therapy toward an FDA submission. The cash infusion lands just as the ...

aws s3 --endpoint-url="http://localhost:4566" website "s3://static-s3-bucket" --index-document index.html --error-document index.html aws s3 --endpoint-url="$endpoint ...

Dalmarkit is released as open source under the Apache License 2.0 license. Bug reports and contributions are welcome at our GitHub repository.